End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
25.67 CNY | -0.73% | -4.04% | +50.03% |
13/05 | Lingrui Pharma Gets Green Light to Market Type 2 Diabetes Drug | MT |
25/04 | Henan Lingrui Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 2,524
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medical and Healthcare
99.8
%
| 2,997 | 99.8 % | 3,304 | 99.8 % | +10.27% |
Others
0.2
%
| 5 | 0.2 % | 7 | 0.2 % | +35.23% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
100.0
%
| 3,002 | 100.0 % | 3,311 | 100.0 % | +10.31% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Wei Xiong
CEO | Chief Executive Officer | 40 | - |
Peng Yu
DFI | Director of Finance/CFO | 55 | - |
Jia Shu Jiang
BRD | Director/Board Member | 51 | - |
Yan Chen
BRD | Director/Board Member | 52 | - |
Guo Xin Feng
BRD | Director/Board Member | 35 | - |
Zi Run Pan
BRD | Director/Board Member | 52 | - |
Xi Zhen Wu
BRD | Director/Board Member | 60 | 18/06/18 |
Gai Li Mao
IRC | Investor Relations Contact | - | - |
Qiang Ye
PRN | Corporate Officer/Principal | 52 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Wei Xiong
CEO | Chief Executive Officer | 40 | - |
Xi Zhen Wu
BRD | Director/Board Member | 60 | 18/06/18 |
Jun Yang
BRD | Director/Board Member | 55 | 18/23/18 |
Zi Run Pan
BRD | Director/Board Member | 52 | - |
Jin Li
CHM | Chairman | 59 | - |
Xia Ying Mei
BRD | Director/Board Member | 54 | 05/20/05 |
Guo Xin Feng
BRD | Director/Board Member | 35 | - |
Yan Chen
BRD | Director/Board Member | 52 | - |
Hui Li
BRD | Director/Board Member | 57 | 05/20/05 |
Bao Dong Cheng
BRD | Director/Board Member | 51 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 575,106,322 | 426,356,733 ( 74.14 %) | 7,966,080 ( 1.385 %) | 74.14 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
19,226,445 | 3.28% | 67,570,764 $ |
Company contact information
Henan Lingrui Pharmaceutical Co., Ltd.
666 Jiangjun Road Xin County
465550, Xinyang
+86 37 6298 8888
http://www.lingrui.comSector
Sales per Business
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+50.03% | 201.64Cr | |
+45.15% | 633.96Cr | |
-14.00% | 460.84Cr | |
+9.54% | 339.05Cr | |
-8.99% | 328.64Cr | |
-6.97% | 173.12Cr | |
-0.31% | 166.99Cr | |
+50.00% | 163.02Cr | |
-10.61% | 159.09Cr | |
+36.19% | 134.19Cr |
- Stock Market
- Equities
- 600285 Stock
- Company Henan Lingrui Pharmaceutical Co., Ltd.